Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jhonatan R Mejia

Biographic Data

ID7985231
NAMEJhonatan R Mejia
GIVEN NAMESJhonatan R
FAMILY NAMEMejia
SIGNATUREMEJIA J R
AFFILIATIONSUniversidad Científica del Sur
ORCID0000-0002-9846-8503
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Disease burden from tobacco consumption in Peru and the projected effect of strengthening control measures

    Open Access•Ariel Bardach, Andrea Alcaraz et al.•ARTICLE•Revista Peruana de Medicina…•2025

    Motivation for the study. Despite progress in tobacco control, the economic and disease burden in Peru remains high. Strengthening smoke-free regulations, implementing plain packaging, banning tobacco promotion and sponsorship, and increasing taxes could reduce it. Main findings. Tobacco use causes 22,350 deaths and 126,000 disease events annually in Peru, resulting in a loss of 1.28% of GDP. Strengthening tobacco control policies would prevent t…

  • Uso de medicamentos en pacientes pediátricos con Covid-19 hospitalizados en un hospital de referencia de Lima, Perú

    Open Access•Medalit Luna-Vílchez, Jhonatan R Mejia et al.•ARTICLE•Revista Peruana de Medicina…•2023

    Motivation for the study. Therapeutic guidelines for COVID-19 in children changed constantly during the pandemic. In Peru, the variation of the treatment during the different waves of the pandemic has not been studied. Main findings. During the third wave, there was a greater number of patients with COVID-19; however, these patients had less severe symptoms. The use of ceftriaxone and azithromycin was less frequent during the third wave. The use …

No prominent works on this page.

  • Uso de medicamentos en pacientes pediátricos con Covid-19 hospitalizados en un hospital de referencia de Lima, Perú

    Open Access•Medalit Luna-Vílchez, Jhonatan R Mejia et al.•ARTICLE•Revista Peruana de Medicina…•2023

    Motivation for the study. Therapeutic guidelines for COVID-19 in children changed constantly during the pandemic. In Peru, the variation of the treatment during the different waves of the pandemic has not been studied. Main findings. During the third wave, there was a greater number of patients with COVID-19; however, these patients had less severe symptoms. The use of ceftriaxone and azithromycin was less frequent during the third wave. The use …

  • Disease burden from tobacco consumption in Peru and the projected effect of strengthening control measures

    Open Access•Ariel Bardach, Andrea Alcaraz et al.•ARTICLE•Revista Peruana de Medicina…•2025

    Motivation for the study. Despite progress in tobacco control, the economic and disease burden in Peru remains high. Strengthening smoke-free regulations, implementing plain packaging, banning tobacco promotion and sponsorship, and increasing taxes could reduce it. Main findings. Tobacco use causes 22,350 deaths and 126,000 disease events annually in Peru, resulting in a loss of 1.28% of GDP. Strengthening tobacco control policies would prevent t…

Medicine (2 works) · Population (2 works) · 2019-20 coronavirus outbreak (1 work) · Consumption (sociology (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 Clinical Research Studies (1 work) · Disease (1 work) · Disease burden (1 work) · Economics (1 work) · Enforcement (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae